Search results
Eli Lilly Has a New Drug That Could Push the Stock Higher
Motley Fool via Yahoo Finance· 4 hours agoWhat is Eli Lilly's latest drug? Donanemab, a treatment to slow the progression of Alzheimer's...
Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma
Clinical Trials Arena via Yahoo Finance· 2 days agoThe company has continued development of Naporafenib, as well as two assets licensed from Joyo...
BrainStorm appoints new COO ahead of ALS study By Investing.com
Investing.com· 11 hours agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a developer of adult stem cell therapies for...
MDMA DOA at FDA Advisory Committee
The National Law Review· 2 hours agoAvid readers know we have speculated that the legalization of psychedelics as a prescription medicine was “closer than ever.” Unfortunately, for...
Combination targeted treatment produces lasting remissions in people with resistant aggressive...
Science Daily· 2 days agoIn a clinical trial at NIH's National Cancer Institute, researchers tested the combination of venetoclax, ibrutinib, prednisone, obinutuzumab ...
Basilea sells rights to microtubule drug to Glioblastoma Foundation
Pharmaceutical Technology via Yahoo Finance· 6 hours agoIn the future, Basilea will continue to take part in any potential commercial partnerships at a...
Takeda’s epilepsy drug misses the mark in two Phase III trials
Clinical Trials Arena via Yahoo Finance· 3 days agoHead of the neuroscience unit at Takeda, Sarah Sheikh, said that the company will be engaging with...
UGA startup receives federal funding for COVID-19 vaccine trial
WXIA-TV Atlanta· 1 hour agoThe funding is part of Project NextGen, a program from the U.S. Department of Health and Human...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 6 days agoLixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) has entered into a significant agreement with the...
BaroPace Announces RelieveHFpEF-II, Its Phase I First-in-Human Trial of PressurePace™, Its...
VentureBeat· 2 days agoPress Release BaroPace Inc. announces its Phase I first-in-human trial of PressurePaceTM, its...
